Hybrid techniques for myocardial regeneration: state of the art and future perspectives
Advances in Interventional Cardiology · 2022 · 18 (4) · 360-365
DOI: 10.5114/aic.2022.121124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Interventional Cardiology, 2022. Verfasst von Anna Kędziora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Myocardium has a limited proliferative capacity, and adult hearts are considered incapable of regenerating after injury. A significant loss in the viable myocardium eventually diminishes the heart's ability to contract synchronously, leading to heart failure. Despite the development in interventional and pharmacological treatment for ischemic heart disease and heart failure, there is a significant number of highly symptomatic patients. For these individuals, treatments that stimulate myocardial regeneration can offer alleviation of dyspnea and angina and improvement in quality of life. Stem cells are known to promote neovascularization and endothelial repair. Various stem cell lines have been investigated over the years to establish those with the highest potential to differentiate into cardiomyocytes, including bone marrow-derived mononuclear cells, mesenchymal stromal cells, CD34+, CD133+, endothelial progenitor cells, and adipose-derived mesenchymal stromal cells. Stem cell studies were based on several delivery pathways: infusion into coronary vessels, direct injection into the injured region of the myocardium, and delivery within the novel bioengineered scaffolds. Acellular materials have also been investigated over the years. They demonstrate the therapeutic potential to promote angiogenesis and release of growth factors to improve the restoration of critical components of the extracellular matrix. This review summarizes hybrid cardiac regeneration treatments that combine novel bioengineering techniques with delivery approaches that cardiac surgeons can provide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland.
- Jagiellonian University Medical College, Krakow, Poland.
- Department of Cardiac Surgery, Regional Specialist Hospital, Grudziadz, Poland.
- Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester MIN, USA.
Zitieren
APA
Kędziora, A., Konstanty-Kalandyk, J., Litwinowicz, R., Mazur, P., Kapelak, B., & Piątek, J. (2022). Hybrid techniques for myocardial regeneration: state of the art and future perspectives. Advances in Interventional Cardiology, 18(4), 360-365. https://doi.org/10.5114/aic.2022.121124
Vancouver
Kędziora A, Konstanty-Kalandyk J, Litwinowicz R, Mazur P, Kapelak B, Piątek J. Hybrid techniques for myocardial regeneration: state of the art and future perspectives. Advances in Interventional Cardiology. 2022;18(4):360-365. doi:10.5114/aic.2022.121124
BibTeX
@article{Kdziora2022,
author = {Kędziora, Anna and Konstanty-Kalandyk, Janusz and Litwinowicz, Radosław and Mazur, Piotr and Kapelak, Bogusław and Piątek, Jacek},
title = {Hybrid techniques for myocardial regeneration: state of the art and future perspectives},
journal = {Advances in Interventional Cardiology},
year = {2022},
volume = {18},
number = {4},
pages = {360--365},
doi = {10.5114/aic.2022.121124}
}
EUVIMED